Strengths and limitations of meta-analysis: larger studies may be more reliable.
暂无分享,去创建一个
S. Yusuf | J. Pogue | M. Flather | M. Farkouh | M D Flather | M E Farkouh | S Yusuf | J M Pogue | Salim Yusuf | M. Flather
[1] S. Horner. Efficacy of Intravenous Magnesium in Acute Myocardial Infarction in Reducing Arrhythmias and Mortalit: Meta‐Analysis of Magnesium in Acute Myocardial Infarction , 1992, Circulation.
[2] R Peto,et al. Why do we need some large, simple randomized trials? , 1984, Statistics in medicine.
[3] M. Flather,et al. Magnesium in acute myocardial infarction , 1995, BMJ.
[4] C. Furberg,et al. Lessons from overviews of cardiovascular trials. , 1987, Statistics in medicine.
[5] R. Collins,et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. , 1985, European heart journal.
[6] K. Woods. Mega-trials and management of acute myocardial infarction , 1995, The Lancet.
[7] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[8] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.,et al. EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.
[9] S. Fletcher,et al. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) , 1992, The Lancet.
[10] E. Antman,et al. Magnesium in acute MI. Timing is critical. , 1995, Circulation.
[11] S. Pocock,et al. Clinical Trials: A Practical Approach , 1984 .
[12] A. M. Skene,et al. TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION Anglo-Scandinavian Study of Early Thrombolysis (ASSET) , 1988, The Lancet.
[13] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.
[14] D. Moher,et al. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews , 1996, The Lancet.
[15] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[16] S Greenland,et al. Invited commentary: a critical look at some popular meta-analytic methods. , 1994, American journal of epidemiology.
[17] S. Pocock,et al. Can meta-analyses be trusted? , 1991, The Lancet.
[18] I Olkin,et al. Meta-analysis: reconciling the results of independent studies. , 1995, Statistics in Medicine.
[19] R Peto,et al. Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials. , 1982, The New England journal of medicine.
[20] P. Ridker,et al. Discordance between Meta-analyses and Large-Scale Randomized, Controlled Trials: Examples from the Management of Acute Myocardial Infarction , 1995, Annals of Internal Medicine.
[21] M. Pfeffer,et al. Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration. , 1995, The American journal of cardiology.
[22] S. Goodman. Meta-analysis and evidence. , 1989, Controlled clinical trials.
[23] T C Chalmers,et al. Problems induced by meta-analyses. , 1991, Statistics in medicine.
[24] A R Jadad,et al. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. , 1995, Controlled clinical trials.
[25] K. Bailey,et al. Inter-study differences: how should they influence the interpretation and analysis of results? , 1987, Statistics in medicine.
[26] T C Chalmers,et al. A comparison of statistical methods for combining event rates from clinical trials. , 1989, Statistics in medicine.
[27] P. Armitage,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.
[28] A. Heagerty,et al. Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality. , 1986, International journal of cardiology.
[29] C. Meinert,et al. Toward prospective registration of clinical trials. , 1988, IRB.
[30] Walker,et al. Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .
[31] T. Chalmers,et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration , 1994, The Lancet.
[32] M. Mardiney,et al. Alteration of cellular ribonucleases associated with murine oncogenic virus infection. , 1978, Biomedicine / [publiee pour l'A.A.I.C.I.G.].
[33] R. Peto,et al. Clinical trial methodology , 1978, Nature.
[34] Raymond C. Schneider,et al. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction , 1995, The Lancet.
[35] A Donner,et al. Approaches to sample size estimation in the design of clinical trials--a review. , 1984, Statistics in medicine.
[36] P. Easterbrook,et al. Publication bias in clinical research , 1991, The Lancet.
[37] R Collins,et al. Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. , 1987, Statistics in medicine.
[38] K. Dickersin,et al. Publication bias and clinical trials. , 1987, Controlled clinical trials.
[39] R. Simes,et al. Confronting publication bias: a cohort design for meta-analysis. , 1987, Statistics in medicine.
[40] R Peto,et al. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. , 1991, BMJ.
[41] R Peto,et al. Why do we need systematic overviews of randomized trials? , 1987, Statistics in medicine.
[42] S. Yusuf. Obtaining medically meaningful answers from an overview of randomized clinical trials. , 1987, Statistics in medicine.
[43] S. Pocock,et al. Estimation issues in clinical trials and overviews. , 1990, Statistics in medicine.
[44] T C Chalmers,et al. Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials. , 1987, Statistics in medicine.
[45] Johan Herlitz,et al. Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .
[46] D L Demets,et al. Methods for combining randomized clinical trials: strengths and limitations. , 1987, Statistics in medicine.